|Datasheet||Specific References||Reviews||Related Products||Protocols|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Human FSTL5 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG13408-G-F|
|Human FSTL5 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG13408-G-H|
|Human FSTL5 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG13408-G-M|
|Human FSTL5 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG13408-G-N|
|Human FSTL5 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG13408-G-Y|
FSTL5 may have molecular function (calcium ion binding) and to localize in various compartments (cytoplasm, extracellular space, extracellular region). FSTL5 expression denoted a dismal prognosis both within and across medulloblastoma subgroups. FSTL5 gene is well expressed, 1.0 times the average gene in this release. The sequence of this gene is defined by 120 GenBank accessions from 113 cDNA clones, some from brain, cerebellum, eye, melanotic melanoma, skin, amygdala, breast and 24 other tissues. FSTL5 gene contains 27 distinct introns. The addition of FSTL5 immunohistochemistry to existing molecular stratification schemes constitutes a reliable and cost-effective tool for prognostication in future clinical trials of medulloblastoma.